PRTN3 and rheumatoid arthritis: The pathogenic potential of several autoantibody classes found in rheumatoid arthritis (RA), especially antibodies targeting post-translational modifications like citrullination (ACPA) and carbamylation (anti-CarP antibodies), was recently substantiated [20, 21].